Related Experiment Video
Updated: Oct 2, 2025

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Peptide epitope-imprinted polymer microarrays for selective protein recognition. Application for SARS-CoV-2 RBD
Zsófia Bognár1, Eszter Supala1, Aysu Yarman2
1BME "Lendület" Chemical Nanosensors Research Group, Department of Inorganic and Analytical Chemistry, Budapest University of Technology and Economics Szt. Gellért tér 4 1111 Budapest Hungary gyurcsanyi.robert@vbk.bme.hu.
We developed a versatile method for creating epitope-imprinted polymer microarrays on SPRi chips for protein recognition. These microarrays show high affinity for SARS-CoV-2 RBD, exceeding natural binding and discriminating against other viruses.
Area of Science:
- Biomaterials Science
- Analytical Chemistry
- Molecular Recognition
Background:
- Surface Plasmon Resonance Imaging (SPRi) enables label-free, multiplexed screening of binding kinetics.
- Molecularly Imprinted Polymers (MIPs) are synthetic receptors with tailored recognition capabilities.
- Developing robust platforms for rapid and specific viral protein detection is crucial.
Purpose of the Study:
- To establish a generic method for generating epitope-imprinted polymer microarrays on SPRi chips.
- To demonstrate the utility of these microarrays for synthesizing and screening high-affinity binders.
- To develop MIPs for recognizing the SARS-CoV-2 spike protein receptor binding domain (RBD).
Main Methods:
- Microspotting of template peptides (RBD nonapeptide GFNCYFPLQ) onto gold SPRi chips.
- Electrosynthesis of a polyscopoletin nanofilm to create one-step MIP arrays.
- Multiplexed, label-free screening of binding kinetics using SPRi.
Main Results:
- Achieved MIPs with dissociation constants (Kd) in the low nanomolar range for RBD, surpassing natural binding affinity.
- Demonstrated high affinity binding to SARS-CoV-2 virus-like particles with excellent discrimination against influenza A (H3N2) virus.
- Confirmed the critical role of specific amino acid sequences in template peptides for MIP binding specificity.
Conclusions:
- The developed MIP-based SPRi microarray platform is a versatile tool for both synthetic and screening applications.
- The MIPs exhibit superior affinity and specificity for SARS-CoV-2 RBD and viral particles.
- This approach offers a promising strategy for rapid diagnostics and molecular recognition applications.
More Related Videos
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022